Media

This talk connects modern AI with translational biotech: use large-scale models and real-world health data to map aging mechanisms, prioritize interventions, and build toward vaccines and therapies for aging-related disease.

In this conversation with Dr. Gil Blander, Prof. Ronjon Nag outlines why longevity requires systems thinking: integrate biomarkers, wearable signals, and clinical context with AI to make clearer, more personalized decisions under uncertainty.

This session is a practical overview of modern AI: what neural networks are, how machine learning differs from rule-based systems, why recent progress happened, and where current systems are useful or limited.

Prof. Ronjon Nag on AI company building, entrepreneurship, and applying technology to longevity and biotech-at the IIT Bay Area Leadership Conference 2023.

Longevity.Technology interview with Prof. Ronjon Nag on peptide vaccines for aging, AI-native discovery, and a ten-year horizon for an aging vaccine.

Company overview video: AGEMICA's AI-native peptide platform, validation stack, and translational roadmap for cancer and longevity.